Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FDMT advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FDMT's RSI Oscillator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for FDMT just turned positive on January 03, 2025. Looking at past instances where FDMT's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .
FDMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where FDMT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FDMT as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for FDMT entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FDMT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.383) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). FDMT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). FDMT's P/S Ratio (10000.000) is very high in comparison to the industry average of (264.084).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FDMT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TGDIX | 16.12 | 0.14 | +0.88% |
TCW Relative Value Large Cap I | |||
KLCSX | 19.16 | 0.14 | +0.74% |
Federated Hermes Kaufmann Large Cap R6 | |||
ODIIX | 132.00 | 0.94 | +0.72% |
Invesco Discovery R6 | |||
GINUX | 28.08 | N/A | N/A |
Goldman Sachs Small Cap Gr Insghts R6 | |||
MOOPX | 10.29 | N/A | N/A |
Mercator International Opportunity A |
A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with QRON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then QRON could also see price increases.
Ticker / NAME | Correlation To FDMT | 1D Price Change % | ||
---|---|---|---|---|
FDMT | 100% | -2.14% | ||
QRON - FDMT | 39% Loosely correlated | N/A | ||
ORMP - FDMT | 38% Loosely correlated | -1.72% | ||
ANNX - FDMT | 36% Loosely correlated | +2.19% | ||
AXON - FDMT | 34% Loosely correlated | +1.37% | ||
SCPH - FDMT | 34% Loosely correlated | -4.09% | ||
More |